ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
North Terrace House,
19 North Terrace,
Hackney, SA, 5069
1300 128 339
Closed over Christmas
(reopened 1 February 2017)
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Research Institute Without Walls
Sunday 26 February 2012
The CFIDS Association of America Breaks Ground On Its “Institute Without Walls”
Association-funded research will form a pipeline to effective treatment for CFS
CHARLOTTE, N.C. – February 23, 2012. The CFIDS Association of America today announces new additions to its comprehensive research initiative to advance objective diagnosis and effective treatment of chronic fatigue syndrome (CFS): five new grant awards, two new projects using resources from a central biobank and curation of a biomarker “hit list” to guide future research. The new investments total $2 million.
“Our ‘research institute without walls’ vision becomes a reality today with the tightly integrated projects led by experts in diverse disciplines,” says CEO Kimberly McCleary. “Rather than expending precious funds – and time – to construct a bricks-and-mortar facility, we have attracted top institutions to put their best minds to work immediately. We function as director and connector, networking carefully selected projects, guiding progress and closely monitoring performance at every step.”
“We’re building a pipeline to effective treatment that includes objective means to diagnose and subtype CFS,” says Suzanne D. Vernon, Ph.D., the Association’s scientific director. “These eight projects extendan initiative begun in 2008 to overcome the ‘one and done’ type studies that have stymied progress in patient care.” Vernon, a microbiologist with more than 15 years of experience in CFS research, directs the Association’s research program.
Five new grants build on past discoveries and explore new scientific terrain:
In addition to these grants, the Association announces two new collaborations through its SolveCFS BioBank, an integrated patient registry and biorepository that houses extensive standardized medical information and biological samples from individuals diagnosed with CFS and healthy controls:
The Association will also work in partnership with start-up venture LogosOmix to develop a "biomarker hit list" for CFS based on the product of a 2009 – 2010 grant to New York University that created a knowledgebase of the CFS literature and text-mining tools.
"These strategically aligned projects transform how research by patient-supported organizations is done. No longer are we simply passive sponsors, we are true partners," states Vernon.
In 2011, the Association established The Catalyst Fund to attract support for its research program. "In science, 'positive' catalysts speed a particular reaction. We're deeply grateful to more than 2,000 individuals, foundations and companies who became catalysts through donations both large and small," says McCleary. She and Vernon will outline the "research institute without walls" strategy, describe the projects and announce a $250,000 gift from best-selling author Laura Hillenbrand at an invitation-only Catalyst Fund event this evening in Charlotte.
The above, with comments, originally appeared here.
blog comments powered by Disqus